Issue: 2013 > May > letter to the editor

High TPMT activity as a risk factor for severe myelosuppression during thiopurine therapy



LETTER TO THE EDITOR
M.L. Seinen, A.A. van Bodegraven, A.B.P. van Kuilenburg, N.K.H. de Boer
PDF

Abstract

No abstract available.